Boxer Capital

Public Investment Fund

Boxer Capital is a vehicle for Tavistock Life Science’s investment in a portfolio of public companies and private equity crossover opportunities. At Boxer Capital, we leverage our internal expertise in evaluating pre-clinical and clinical data to generate outsized returns for company founders and employees as well for our investor the Tavistock Group. Boxer Capital has a focus on biotechnology drug development companies across multiple therapeutic indications.